Tonix Pharmaceuticals Holding Corp. (TNXP) financial statements and ratios from SEC XBRL: revenue $13.11M (TTM), net margin -946.2%, revenue growth 29.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $13.11M |
| Net Margin | -946.2% |
| Revenue Growth (YoY) | 29.8% |
| EPS Growth (YoY) | -91.7% |
| FCF Growth (YoY) | 69.1% |
| Price / Book | 0.90 |
| Price / Sales | 6.55 |
| FCF Yield | -118.1% |
| Altman Z-Score | -1.75 (distress) |
| Sector P/E (Healthcare) | 21.7 |
TNXP overview · TNXP earnings · TNXP KPIs · TNXP investor relations · TNXP ownership · TNXP peers · TNXP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.